Catalyst
Slingshot members are tracking this event:
Roche (RHHBY) Initiates Two Phase 3 Studies Evaluating Tecentriq + Cotellic + Zelboraf in Patients with Advanced Melanoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tecentriq, Cotellic, Zelboraf, Advanced Melanoma
